News

3D Systems Investors: Join the Class Action Lawsuit Now

3D Systems Investors: Join the Class Action Lawsuit Now

Attention 3D Systems Investors: A Class Action Lawsuit Opportunity

Attention, investors of 3D Systems Corporation (NYSE: DDD)! This is an important announcement for you. If you have experienced substantial financial losses, an opportunity has arisen for you to participate in a class action lawsuit against the company. This legal action is being organized by Bronstein, Gewirtz & Grossman, LLC, a reputable law firm committed to representing investors in securities fraud cases.

Your Rights as an Investor

What does this mean for you? If you purchased or acquired 3D Systems securities during the designated period, you may be eligible to join the lawsuit. This case centers around alleged violations of federal securities laws by the company's leadership. Accusations state that there were materially false and misleading statements made about the company's business practices, operations, and other compliance matters.

Class Period Defined

The class action lawsuit pertains specifically to the period between August 13, 2024, and May 13, 2025. Investors who engaged with 3D Systems within this timeframe are encouraged to take action. Joining this lawsuit not only empowers you as an investor but also holds the company accountable for its decisions and communications that potentially caused financial damage.

Understanding the Case's Contents

The complaint outlines several key allegations against 3D Systems. It claims that the company downplayed the adverse effects of reduced customer spending while exaggerating its stability in a competitive market. Furthermore, it points out that the updated milestones within their United Partnership could negatively impact important revenue streams, particularly for their Regenerative Medicine Program.

Why Take Action Now?

Being part of this lawsuit means standing up for your rights as an investor. If you wish to see the legal complaint and understand your position better, you can do so through the designated law firm's website. Time is of the essence; the deadline to request lead plaintiff status is approaching, and you don’t need to worry if you aren't the lead plaintiff to partake in any recovery.

Financial Representation with No Upfront Cost

One of the standout features of this class action lawsuit is that it operates on a contingency fee basis. This means that if the case is successful, the law firm will seek reimbursement for its expenses and attorney fees from the total recovery amount. Essentially, you have the chance to recover some or all of your losses without any upfront financial commitment.

Why Choose Bronstein, Gewirtz & Grossman, LLC?

With a track record of recovering hundreds of millions of dollars for investors across the nation, Bronstein, Gewirtz & Grossman is an established leader in representing investor interests. Their expertise in securities fraud class actions underlines their capability to advocate for those who have suffered due to potential misconduct by corporations.

Stay Connected for Updates

For those interested in ongoing updates regarding this class action and future legal communications, following Bronstein, Gewirtz & Grossman on their social media platforms will keep you informed. They provide valuable information regarding investor rights and legal processes that affect your investments.

Frequently Asked Questions

What is the primary goal of this class action lawsuit?

The main objective is to recover damages for investors who experienced financial losses due to misleading corporate communications from 3D Systems.

How do I know if I am eligible to join the lawsuit?

If you purchased or acquired 3D Systems securities between August 13, 2024, and May 13, 2025, you are likely eligible.

Are there any costs involved in joining the lawsuit?

No, there are no upfront costs. The law firm operates on a contingency fee basis.

What should I do if I want to join the lawsuit?

You should reach out to Bronstein, Gewirtz & Grossman for guidance on how to proceed as a participant in the class action.

Can I still recover if I am not the lead plaintiff?

Yes, participating in the lawsuit does not require you to be the lead plaintiff to share in any potential recovery.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cooper's Heat Pump Campaign Fuels Denver's Community

Updated Category News Views 124

How Heat Pumps Meet Philanthropy in Denver Alright, let me lay it out for you—a story as much about ingenuity as generosity. Cooper Heating & Cooling, donning their ‘Cooper Green Team’ capes, just wrapped up one heck of a community-driven campaign. They dropped a cool $5,000 into the coffers of We Don't Waste, a Denver nonprofit focused on food recovery. This...

Continue Reading
Ares Management Faces Fintech with $691B Assets

Updated Category News Views 170

Anticipation Builds: Ares Awaits TD Cowen Spotlight Ah, Ares Management, the Wall Street heavyweight clocking a colossal $691 billion in assets. Now, they’re angling to dish out some strategic insights. With the TD Cowen 2026 Financials & Fintech Conference set to roll on November 18, what’s better than watching these investment titans take the stage with their CFO...

Continue Reading
Surgery Partners and ADT Sales Under Legal Scrutiny

Updated Category News Views 6

Shareholder Scrutiny on Mergers It's no secret that corporate mergers often kick up a fuss, but when insiders get a juicy payday while regular shareholders play catch-up, folks raise eyebrows. Halper Sadeh LLC, that gutsy law firm, isn't shy about going after possible dirty deals, and they've got their eyes on a few names related to potential securities law violations and...

Continue Reading
BD Sets Stage for Investor Day in December 2026

Updated Category News Views 61

BD's Investor Day: A Peek into the Future Say what you will about investor meets, but BD (Becton, Dickinson and Company) throwing its shindig on December 10, 2026, could be a highlight on the calendar if you're eyeing the medical technology sector. Scheduled in New York, this event is gearing up to be a canvas for BD's higher-ups to sketch out their roadmap. If you’re...

Continue Reading
Gulliver Prep's New STEAM Complex to Transform Miami

Updated Category News Views 0

Gulliver Prep Leads the Charge in Education Innovation Gulliver Preparatory School just dropped a bombshell in Miami—almost literally, with their shovels hitting the dirt for a new 95,000-square-foot STEAM complex. It's not some lip-service to educational buzzwords either. This project's part of 'The Next 100: The Centennial Campaign for Gulliver,' a mega drive to...

Continue Reading
IASO Bio's In Vivo CAR-T: A Game Changer for Oncology?

Updated Category News Views 52

You ever feel like you're watching history happen right in front of you? That's the vibe with IASO Bio's latest move in the realm of oncology. This outfit just scored a major victory, getting China's NMPA and the U.S. FDA to greenlight their IASO208, a CD20-targeting in vivo CAR-T therapy. It's not every day you see a company land dual regulatory nods like...

Continue Reading
Real Estate Decisions in Hospitality: Buy or Lease?

Updated Category News Views 0

Venturing into Hospitality Real Estate If you're in the hospitality game, the question of whether to buy or to lease your property can loom like a shadow or shine like an opportunity. The latest episode of the Owner's Edge Podcast by Bielat Santore & Company dives into this headfirst, armed with over 45 years of brokering experience in hospitality transactions. They don't...

Continue Reading
O-I Glass Faces Class Action: What Investors Must Know

Updated Category News Views 35

The Unsettling News for O-I Glass Investors Let me dive right into this mess about O-I Glass, Inc. (NYSE:OI). If you're tangled up in their stock, you probably felt that 15.01% nosedive in your portfolio recently. That's no minor blip. On July 28, 2026, as stocks were virtually put through the shredder, O-I Glass announced they had to cut down their financial guidance for...

Continue Reading
Gilat's Revenue Dip Spurs Legal Scrutiny for Investors

Updated Category News Views 51

Gilat Satellite's Surprise Revenue Shortfall If anybody thought the satellite business was all about science fiction-esque technology, here's a reality check: when earnings don't meet expectations, shareholders get jittery. This seems to be exactly what's happening with Gilat Satellite Networks Ltd. (NASDAQ: GILT). After twice reaffirming their fiscal 2026 revenue...

Continue Reading
Insulin Delivery Devices: A Billion-Dollar Surge

Updated Category News Views 20

When's the last time you saw a medical device market promising a $10 billion leap in under five years? Yeah, the insulin delivery devices market's got that kind of upside, projected to skyrocket from $16.92 billion in 2026 to a whopping $26.37 billion by 2031. That's a 9.3% annual growth rate. The numbers and the stakes are both staggering. Regional and Segment Leaders...

Continue Reading

Top 5 Most Recently Viewed Articles

Embracing AI in Recruitment: A New Era for Job Seekers

Updated Category News Views 74

The Growing Impact of AI in Recruitment In today’s competitive job market, businesses are increasingly recognizing the benefits that artificial intelligence (AI) brings to the recruitment process. A recent survey found that a substantial portion—over 60%—of job seekers feel quite at ease with AI taking charge of the recruitment process. This involvement can span...

Continue Reading
Seagate Technology's Upcoming Earnings: What Investors Should Know

Updated Category News Views 90

Seagate Technology's Earnings Report Approaches Data storage innovator Seagate Technology (NASDAQ: STX) is set to announce its earnings results imminently, presenting investors with an important opportunity to assess the company’s performance. With high expectations surrounding this earnings release, understanding the key factors that might influence the report is...

Continue Reading
Revolutionary Blood Test For Early Alzheimer's Diagnosis Unveiled

Updated Category News Views 150

Innovative Blood Test for Alzheimer's Diagnosis A groundbreaking international research initiative is currently testing a finger prick blood test to aid in diagnosing Alzheimer's disease, potentially before symptoms manifest. This trial focuses on identifying three specific proteins in the blood connected to Alzheimer's, comparing results with the traditional diagnostic...

Continue Reading
AGNC Investment Prepares for Earnings Announcement

Updated Category News Views 139

Anticipating Earnings for AGNC Investment AGNC Investment (NASDAQ: AGNC) is gearing up to announce its quarterly earnings. Investors are eager to know the company's financial health and future outlook. According to analysts, AGNC Investment is projected to report an earnings per share (EPS) of $0.51 for this quarter. This figure is critical for investors tracking the...

Continue Reading
Investigation Launched into Nabors Industries Merger and Fairness

Updated Category News Views 175

Overview of the Investigation on Nabors Industries Ltd. Halper Sadeh LLC, a dedicated investor rights law firm, has initiated an investigation regarding the proposed merger between Nabors Industries Ltd. (NYSE: NBR) and Parker Wellbore. The focus of this inquiry is to determine whether the terms of this merger are fair to the shareholders of Nabors Industries. This...

Continue Reading